Satellos Bioscience Inc. (MSCL) — Strategic Asset Allocation Index
Satellos Bioscience Inc. (MSCL) has a Strategic Asset Allocation Index of 0.0% as of December 2025. Strategic assets (PP&E of CA$5.00K plus long-term investments of CA$0.00) total CA$5.00K, measured against net assets of CA$27.73 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Satellos Bioscience Inc. Strategic Asset Allocation Index (2021–2025)
This chart shows how Satellos Bioscience Inc.'s Strategic Asset Allocation Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 0.0%, representing strategic assets of CA$5.00K against net assets of CA$27.73 Million CAD. Explore MSCL cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Satellos Bioscience Inc. (2021–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Satellos Bioscience Inc. from 2021 to 2025, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see MSCL market cap overview.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.0% | CA$5.00K | CA$5.00K | CA$0.00 | CA$27.73 Million | ▲ +0.0 pp |
| 2024 | 0.0% | CA$4.00K | CA$4.00K | CA$0.00 | CA$67.86 Million | ▼ -0.1 pp |
| 2023 | 0.1% | CA$44.73K | CA$13.82K | CA$30.91K | CA$40.67 Million | ▼ -1.0 pp |
| 2022 | 1.1% | CA$36.79K | CA$5.85K | CA$30.95K | CA$3.37 Million | ▲ +1.1 pp |
| 2021 | 0.0% | CA$0.00 | CA$- | CA$0.00 | CA$10.48 Million | — |